Risk stratification in medullary thyroid cancer: Moving beyond static anatomic staging

Oral Oncology

Volumn 49, Issue 7, 2013, Pages 695-701

  Tuttle, R Michael ^a   Ganly, I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Medullary thyroid cancer; Prognosis; Risk stratification; Staging

Indexed keywords

CALCITONIN; PENTAGASTRIN; PROCALCITONIN; THYROGLOBULIN;

CALCITONIN BLOOD LEVEL; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CAUSE OF DEATH; DIFFERENTIATED THYROID CANCER; DISEASE COURSE; DISTANT METASTASIS; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; NECK DISSECTION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGIONAL METASTASIS; REVIEW; RISK ASSESSMENT; SYSTEMIC THERAPY; THYROGLOBULIN BLOOD LEVEL; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT RESPONSE;

EID: 84879072408     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.03.443     Document Type: Article

References (73)

1. AJCC Cancer Staging manual, 7th ed. New York: Springer-Verlag; 2009.
2. S.K. Baek, K.Y. Jung, S.M. Kang, S.Y. Kwon, J.S. Woo, and S.H. Cho Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma Thyroid 20 2 2010 147 152
3. S. Orlov, D. Orlov, M. Shaytzag, M. Dowar, V. Tabatabaie, and P. Dwek Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma Head Neck 31 6 2009 782 788
4. R.M. Tuttle, H. Tala, J. Shah, R. Leboeuf, R. Ghossein, and M. Gonen Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system Thyroid 20 12 2010 1341 1349
5. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, and S.J. Mandel Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 11 2009 1167 1214
6. F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, and W. Wiersinga European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 6 2006 787 803
7. F. Pitoia, L. Ward, N. Wohllk, C. Friguglietti, E. Tomimori, and A. Gauna Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer Arq Bras Endocrinol Metabol 53 7 2009 884 887
8. M.G. Castagna, F. Maino, C. Cipri, V. Belardini, A. Theodoropoulou, and G. Cevenini Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients Eur J Endocrinol 165 3 2011 441 446
9. F. Vaisman, D. Momesso, D. Bulzico, C. Pessoa, F. Dias, and R. Corbo Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy Clin Endocrinol (Oxf) 2012
10. F. Vaisman, HP. Tala Jury, R. Grewal, and R. Tuttle In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response Thyroid 21 12 2011 1317 1322
11. R.M. Tuttle Risk-adapted management of thyroid cancer Endocr Pract 14 6 2008 764 774
12. S.Y. Boostrom, C.S. Grant, G.B. Thompson, D.R. Farley, M.L. Richards, and T.L. Hoskin Need for a revised staging consensus in medullary thyroid carcinoma Arch Surg 144 7 2009 663 669
13. E. Kebebew, P.H. Ituarte, A.E. Siperstein, Q.Y. Duh, and O.H. Clark Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems Cancer 88 5 2000 1139 1148
14. S. Roman, R. Lin, and J.A. Sosa Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases Cancer 107 9 2006 2134 2142
15. S. Leboulleux, E. Baudin, J.P. Travagli, and M. Schlumberger Medullary thyroid carcinoma Clin Endocrinol (Oxf) 61 3 2004 299 310
16. S. Leboulleux, C. Rubino, E. Baudin, B. Caillou, D.M. Hartl, and J.M. Bidart Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis J Clin Endocrinol Metab 90 10 2005 5723 5729
17. J. Barbet, L. Campion, F. Kraeber-Bodere, and J.F. Chatal Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma J Clin Endocrinol Metab 90 11 2005 6077 6084
18. J.R. Clark, T.R. Fridman, M.J. Odell, J. Brierley, P.G. Walfish, and J.L. Freeman Prognostic variables and calcitonin in medullary thyroid cancer Laryngoscope 115 8 2005 1445 1450
19. K. Cupisti, A. Wolf, A. Raffel, M. Schott, D. Miersch, and Q. Yang Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years Ann Surg 246 5 2007 815 821
20. R. Elisei, V. Bottici, F. Luchetti, G. Di Coscio, C. Romei, and L. Grasso Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders J Clin Endocrinol Metab 89 1 2004 163 168
21. S.A. Hundahl, I.D. Fleming, A.M. Fremgen, and H.R. Menck A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns] Cancer 83 12 1998 2638 2648
22. K. Kameyama, and H. Takami Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002 Endocr J 51 5 2004 453 456
23. E. Modigliani, R. Cohen, J.M. Campos, B. Conte-Devolx, B. Maes, and A. Boneu Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs a calcitonine Clin Endocrinol (Oxf) 48 3 1998 265 273
24. G. Rendl, M. Manzl, W. Hitzl, P. Sungler, and C. Pirich Long-term prognosis of medullary thyroid carcinoma Clin Endocrinol (Oxf) 69 3 2008 497 505
25. J.A. van Heerden, C.S. Grant, H. Gharib, I.D. Hay, and D.M. Ilstrup Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma Ann Surg 212 4 1990 395 400 discussion 400-391
26. T. Weber, T. Schilling, K. Frank-Raue, M. Colombo-Benkmann, U. Hinz, and R. Ziegler Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas Surgery 130 6 2001 1044 1049
27. E. Kandil, M.M. Gilson, H.H. Alabbas, A.P. Tufaro, A. Dackiw, and R.P. Tufano Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer Ann Surg Oncol 18 4 2011 1028 1034
28. M.D. Leggett, S.L. Chen, P.D. Schneider, and S.R. Martinez Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma Ann Surg Oncol 15 9 2008 2493 2499
29. D.T. Abraham, T.H. Low, M. Messina, N. Jackson, A. Gill, and A.S. Chou Medullary thyroid carcinoma: long-term outcomes of surgical treatment Ann Surg Oncol 18 1 2011 219 225
30. M.E. Dottorini, A. Vignati, L. Mazzucchelli, G. Lomuscio, and L. Colombo Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients J Nucl Med 38 5 1997 669 675
31. Y. Ito, A. Miyauchi, T. Yabuta, M. Fukushima, H. Inoue, and C. Tomoda Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution World J Surg 33 1 2009 58 66
32. U. Bergholm, R. Bergstrom, and A. Ekbom Long-term follow-up of patients with medullary carcinoma of the thyroid Cancer 79 1 1997 132 138
33. G. Pellegriti, S. Leboulleux, E. Baudin, N. Bellon, C. Scollo, and J.P. Travagli Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging Br J Cancer 88 10 2003 1537 1542
34. M.A. Walter, C. Meier, T. Radimerski, F. Iten, M. Kranzlin, and J. Muller-Brand Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer Cancer 116 1 2010 31 40
35. J.A. Meijer, S. le Cessie, W.B. van den Hout, J. Kievit, J.W. Schoones, and J.A. Romijn Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis Clin Endocrinol (Oxf) 72 4 2010 534 542
36. A. Machens, and H. Dralle Benefit-risk balance of reoperation for persistent medullary thyroid cancer Ann Surg 2012
37. A. Machens, and H. Dralle Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system Ann Surg 257 2 2013 323 329
38. A. Machens, O. Gimm, J. Ukkat, R. Hinze, U. Schneyer, and H. Dralle Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis Cancer 88 8 2000 1909 1915
39. B. Panigrahi, S.A. Roman, and J.A. Sosa Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines? Ann Surg Oncol 17 6 2010 1490 1498
40. Ho A, Yu C, Toset A, Palmer FL, Shah JP, Patel S, et al. In: A predictive model for recurrence in medullary thyroid cancer 8th international conference on head and neck cancer, Toronto Canada, July 2012; 2012.
41. R.T. Kloos, C. Eng, D.B. Evans, G.L. Francis, R.F. Gagel, and H. Gharib Medullary thyroid cancer: management guidelines of the American Thyroid Association Thyroid 19 6 2009 565 612
42. National Comprehensive Cancer Network. Thyroid Carcinoma v1.2013. 2013. < http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#thyroid > [accessed 23.01.13].
43. C.S. Hill Jr., M.L. Ibanez, N.A. Samaan, M.J. Ahearn, and R.L. Clark Medullary (solid) carcinoma of the thyroid gland: an analysis of the M. D. Anderson Hospital experience with patients with the tumor, its special features, and its histogenesis Medicine 52 2 1973 141 171
44. J. Kratzsch, A. Petzold, F. Raue, W. Reinhardt, M. Brocker-Preuss, and R. Gorges Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer Clin Chem 57 3 2011 467 474
45. A. Algeciras-Schimnich, C.M. Preissner, J.P. Theobald, M.S. Finseth, and S.K. Grebe Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma J Clin Endocrinol Metab 94 3 2009 861 868
46. H. Bihan, K.L. Becker, R.H. Snider, E. Nylen, L. Vittaz, and C. Lauret Calcitonin precursor levels in human medullary thyroid carcinoma Thyroid 13 8 2003 819 822
47. L.G. Brandao, B.G. Cavalheiro, and C.R. Junqueira Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases Clinics (Sao Paulo, Brazil) 64 9 2009 849 856
48. T. Gawlik, A. d'Amico, S. Szpak-Ulczok, A. Skoczylas, E. Gubala, and A. Chorazy The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report Thyroid Res 3 1 2010 10
49. J.F. Moley, and M.K. DeBenedetti Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection Ann Surg 229 6 1999 880 887 discussion 887-888
50. C. Scollo, E. Baudin, J.P. Travagli, B. Caillou, N. Bellon, and S. Leboulleux Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer J Clin Endocrinol Metab 88 5 2003 2070 2075
51. J. Ukkat, O. Gimm, M. Brauckhoff, U. Bilkenroth, and H. Dralle Single center experience in primary surgery for medullary thyroid carcinoma World J Surg 28 12 2004 1271 1274
52. R. Cohen, J.M. Campos, C. Salaun, H.M. Heshmati, J.L. Kraimps, and C. Proye Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC) J Clin Endocrinol Metab 85 2 2000 919 922
53. A. Machens, and H. Dralle Biomarker-based risk stratification for previously untreated medullary thyroid cancer J Clin Endocrinol Metab 95 6 2010 2655 2663
54. A. Machens, U. Schneyer, H.J. Holzhausen, and H. Dralle Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level J Clin Endocrinol Metab 90 4 2005 2029 2034
55. D.T. Yip, M. Hassan, K. Pazaitou-Panayiotou, D.T. Ruan, A.A. Gawande, and R.D. Gaz Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma Surgery 150 6 2011 1168 1177
56. A. Machens, J. Ukkat, S. Hauptmann, and H. Dralle Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis Arch Surg 142 3 2007 289 293 discussion 294
57. O. Gimm, J. Ukkat, and H. Dralle Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma World J Surg 22 6 1998 562 567 discussion 567-568
58. D. Abraham, N. Jackson, J.S. Gundara, J. Zhao, A.J. Gill, and L. Delbridge MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets Clin Cancer Res 17 14 2011 4772 4781
59. P.K. Mehrotra, A. Mishra, S.K. Mishra, G. Agarwal, A. Agarwal, and A.K. Verma Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India World J Surg 35 6 2011 1273 1280
60. A. Rios, J.M. Rodriguez, J.M. Acosta, M.D. Balsalobre, N. Torregrosa, and J. Sola Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma Ann Surg Oncol 17 9 2010 2444 2451
61. Y. Ito, M. Fukushima, C. Tomoda, H. Inoue, M. Kihara, and T. Higashiyama Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment Endocr J 56 6 2009 759 766
62. P. Bumming, H. Ahlman, B. Nilsson, O. Nilsson, B. Wangberg, and S. Jansson Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma? Langenbecks Arch Surg 393 5 2008 699 703
63. S. Franc, P. Niccoli-Sire, R. Cohen, S. Bardet, B. Maes, and A. Murat Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma Clin Endocrinol (Oxf) 55 3 2001 403 409
64. M.E. Girelli, S. Dotto, D. Nacamulli, M. Piccolo, D. De Vido, and T. Russo Prognostic value of early postoperative calcitonin level in medullary thyroid carcinoma Tumori 80 2 1994 113 117
65. S.I. Ismailov, and N.R. Piulatova Postoperative calcitonin study in medullary thyroid carcinoma Endocr Relat Cancer 11 2 2004 357 363
66. S.A. Boikos, and C.A. Stratakis Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment Histol Histopathol 23 1 2008 109 116
67. A. Laure Giraudet, A. Al Ghulzan, A. Auperin, S. Leboulleux, A. Chehboun, and F. Troalen Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times Eur J Endocrinol 158 2 2008 239 246
68. A. Miyauchi, T. Onishi, S. Morimoto, S. Takai, F. Matsuzuka, and K. Kuma Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma Ann Surg 199 4 1984 461 466
69. M.F. Saad, H.A. Fritsche Jr., and N.A. Samaan Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid J Clin Endocrinol Metab 58 5 1984 889 894
70. A.V. Stepanas, N.A. Samaan, C.S. Hill Jr., and R.C. Hickey Medullary thyroid carcinoma: importance of serial serum calcitonin measurement Cancer 43 3 1979 825 837
71. J.M. Dora, M.H. Canalli, C. Capp, M.K. Punales, J.G. Vieira, and A.L. Maia Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature Thyroid 18 8 2008 895 899
72. M. Osaka, J. Soga, Y. Tamiya, and T. Suzuki Dedifferentiation of neoplastic cells in medullary thyroid carcinoma: report of a case Surg Today 29 11 1999 1189 1194
73. T.S. Wang, I.T. Ocal, J.A. Sosa, H. Cox, and S. Roman Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma Thyroid 18 8 2008 889 894